News

 A study using a new imaging tool, optical coherence tomography (OCT), offered a new look at the composition of carotid artery...

OCT

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the Transcatheter Cardiovascular Therapeutics (...

July 18, 2014 — Avinger announced that John Pigott, M.D., of Jobst Vascular Institute, Toledo, Ohio, enrolled the first patient in the VISION trial, a global investigational device exemption (IDE...

Watchman, LAA occluder

Interventional thought leaders at the American College of Cardiology (ACC) 2014 meeting shared their predictions about the cutting-edge technologies emerging today that will become commonplace in...

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights about the latest cardiovascular technologies and treatment techniques. These...

intravascular imaging ffr ultrasound ivus optical coherence tomography oct cath

In an expert consensus document e-published in Catheterization and Cardiovascular Interventions (CCI), the Society for Cardiovascular Angiography and Interventions (...

OCT st. jude imaging systems cath lab advanced visualization ilumiens

St. Jude Medical Inc. announced the U.S. Food and Drug Administration (FDA) approval and launch of its Ilumien Optis PCI optimization system, a new technology designed to provide physicians with a...

Avinger Inc. has received CE Mark approval for Pantheris – a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked...

St. Jude Medical gained CE mark approval of its Ilumien Optis percutaneous coronary intervention (PCI) optimization system to better visualize stent planning and navigation. The system integrates...

December 26, 2012 — St. Jude Medical Inc. announced the first patient enrollment in its ILUMIEN I clinical study. The observational study is designed to show the optimal way optical coherence...

Volcano Corporation announced that it has entered into a definitive agreement to acquire Sync-Rx Ltd., a privately-held company based in Israel that develops advanced software applications that...

Avinger Ocelot OCT CTO catheter

The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT) catheter to help cross...

CONNECT II Clinical Trial CTO Crossing Catherter Peripheral Artery Disease

Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with...

July 20, 2012 — The ability to see inside the arteries of vascular disease patients in high resolution before and during stenting procedures can offer valuable information. A new study of...

July 5, 2012 — Avinger Inc., a medical device manufacturer of multifunctional catheters, announced in June that it has successfully completed enrollment in its CONNECT II global clinical trial.

June 8, 2012 — Austin Heart announced its participation in CONNECT II, a global clinical trial that gives physicians access to a new imaging technology...

April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology,...

March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial evaluating the safety and efficacy of Ocelot. The device is the first...

Avinger Inc. announced the enrollment of the first European patient in the CONNECT II global clinical trial. The first patient was enrolled by Dr. Bernhard Reimers at Ospedale di Mirano in Mirano...

October 26, 2011 – St. Jude Medical announced it has received U.S. Food and Drug Administration (FDA) clearance for its Ilumien system, the first integrated diagnostic technology that combines...